SUMO4 and its role in type 1 diabetes pathogenesis
- 28 January 2008
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 24 (2), 93-102
- https://doi.org/10.1002/dmrr.797
Abstract
Susceptibility to type 1 diabetes (T1D) is determined by interactions of multiple genes with unknown environmental factors. Despite the characterization of over 20 susceptibility regions for T1D, identification of specific genes in these regions is still a formidable challenge. In 2004, we first reported the cloning of a novel, small ubiquitin‐like modifier (SUMO) gene, SUMO4, in the IDDM5 interval on chromosome 6q25, and presented strong genetic and functional evidence suggesting that SUMO4 is a T1D susceptibility gene. Subsequent studies have consistently confirmed this association in multiple Asian populations despite controversial observations in Caucasians. In this review, we will update the genetic evidence supporting SUMO4 as a T1D susceptibility gene and discuss the possible explanations for the discrepant associations observed in Caucasians. We will then discuss the mechanisms through which SUMO4 contributes to the pathogenesis of T1D. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 104 references indexed in Scilit:
- SUMO modification of Sam68 enhances its ability to repress cyclin D1 expression and inhibits its ability to induce apoptosisOncogene, 2006
- Suppression of STAT3 Activity by Duplin, Which Is a Negative Regulator of the Wnt SignalThe Journal of Biochemistry, 2006
- Cytoprotection of beta cells: rational gene transfer strategiesDiabetes/Metabolism Research and Reviews, 2006
- Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stressBiochemical and Biophysical Research Communications, 2005
- SUMO wrestling with type 1 diabetesJournal of Molecular Medicine, 2005
- A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetesNature Genetics, 2004
- A Mutant Stat5b with Weaker DNA Binding Affinity Defines a Key Defective Pathway in Nonobese Diabetic MicePublished by Elsevier BV ,2004
- The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expressionOncogene, 2003
- TRAF6 and C‐SRC induce synergistic AP‐1 activation via PI3‐kinase–AKT–JNK pathwayEuropean Journal of Biochemistry, 2003
- Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8Human Molecular Genetics, 1996